Summary
When repeated epinephrine infusions are given to normal dogs as a partial stress model, there is exaggerated hyperglycaemia, associated with reduced plasma insulin levels and markedly decreased glucose clearance. In the present study, we have examined the hormonal and metabolic responses to two successive 60-min epinephrine (0.1 μg-kg−1·min−1) infusions with or without concomitant infusion of beta endorphin (0.3 μg·kg−1·min−1) in 6 alloxan-diabetic dogs. These studies have been compared to similar studies in 5 normal dogs.
In the diabetic dogs, plasma glucose rose from 12.3±2.2 to 16.2±2.4 mmol/l (p<0.001) in response to the first epinephrine infusion and rose further to 18.1±2.5 mmol/l (p<0.001) during the second epinephrine infusion. The increases in plasma glucagon and glucose production were comparable with both infusions, but considerably greater than previously observed in normal dogs.
In normal dogs, beta endorphin diminished the insulin response to the first epinephrine infusion (p<0.02), and abolished this response to the second (p<0.05). In addition beta endorphin also diminished the glucagon response to the second epinephrine infusion (p<0.01) and greatly potentiated epinephrine-induced suppression of glucose metabolic clearance during both infusions (p<0.001). However, beta endorphin did not appreciably alter the hyperglycaemic response to epinephrine due to a concomitant attenuation of the epinephrine-induced increase in hepatic glucose production.
In contrast to normal dogs, beta endorphin did not modulate the effects of either the first or second epinephrine infusion on glucose kinetics in diabetic dogs. Also, beta endorphin failed to inhibit glucagon or insulin secretion in response to epinephrine in the diabetic animals. Since the alloxan-diabetic and normal dogs respond differently to the combined infusion of beta endorphin and epinephrine we conclude that the effects of beta endorphin observed in the normal dogs are dependent upon intact pancreatic endocrine function.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Wilmore DW (1976) Carbohydrate metabolism in trauma. Clin Endocrinol Metab 5: 731–745
Halter JB, Beard JC, Porte D Jr (1984) Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction. Am J Physiol 247: E47-E52
Bondy PK, Felig P (1974) Disorders of carbohydrate metabolism. Bondy PK, Rosenberg LE (eds) Duncan's diseases of metabolism, 7th edn. Saunders, Philadelphia, pp 221–340
El-Tayeb KMA, Brubaker PL, Vranic M, Lickley HLA (1985) Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs. Diabetes 34: 1293–1300
Perez G, Kemmer FW, Lickley HLA, Vranic M (1981) Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs. Am J Physiol 241: E328-E335
Awoke S, Voyles NR, Bhathena SJ, Tanenberg RJ, Recant L (1984) Alterations of plasma opioid activity in human diabetics. Life Sci 34: 1999–2006
El-Tayeb KMA, Brubaker PL, Lickley HLA, Vranic M (1986) Effects of opiate receptor blockade on normoglycemia and hypoglycemic glucoregulation. Am J Physiol 250: E 236-E 242
Viveros OH, Diliberto EJ, Hazum E, Chang K-J (1979) Opiatelike materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Mol Pharmacol 16: 1101–1108
Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW (1979) Endogenous opioid peptides: multiple agonists and receptors. Nature 267: 495–499
Zukin RS, Zukin SR (1981) Multiple opiate receptors: emerging concepts. Life Sci 29: 2681–2690
Giugliano D (1984) Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 7: 92–98
Ipp E, Dhuorajiwala J, Pugh W, Moosa AR, Rubenstein AH (1982) Effects of an enkephalin analog on pancreatic endocrine function and glucose homeostasis in normal and diabetic dogs. Endocrinology 111: 2110–2116
Radosevich PM, Williams PE, Lacy DB, McRae JR, Steiner KE, Cherrington AD, Lacy WW, Abumrad NN (1984) Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest 74: 1473–1480
Vranic M, Kawamori R, Pek S, Kovacevic N, Wrenshall G (1976) The essentiality of insulin and the role of glucagon in regulating glucose utilization and production in exercising dogs. J Clin Invest 57: 245–255
Christensen NJ, Christensen SE, Hansen AP, Lunder R (1975) The effect of somatostatin on plasma nor adrenaline and plasma adrenaline concentrations during exercise and hypoglycemia. Metabolism 24: 1267–1272
Kemmer FW, Lickley HLA, Gray DE, Perez G, Vranic M (1982) State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes. Am J Physiol 242: E428-E436
Gauthier C, El-Tayeb K, Vranic H, Lickley HLA (1986) Glucoregulatory role cortisol and epinephrine interactions studied in adrenalectomized dogs. Am J Physiol 250: E393-E401
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420–430
Radziuk J, Norwich KH, Vranic M (1978) Experimental validating of measurements of glucose turnover in nonsteady state. Am J Physiol 234: E84-E93
Radziuk J, Lickley HLA (1985) The metabolic clearance of glucose: measurement and meaning. Diabetologia 28: 315–322
Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York
Reid RL, Yen SSC (1981) B-endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab 52: 592–594
Ipp E, Dobbs RH (1978) Morphine and B-endorphin influence the secretion of the endocrine pancrease. Nature (London) 276: 190–191
Bone RC, Jacobs ER, Potter DM, Hiller FC, Wilson FJ Jr (1981) Endorphins in endotoxin shock. Microcirculation 1: 285–295
Wardlaw SL, Wehrenberg WB, Ferin M, Carmel PW, Frantz AG (1980) High levels of B-endorphin in hypophyseal portal blood. Endocrinology 106: 1323–1326
El-Tayeb KMA, Gauthier CJT, Brubaker PL, Lickley HLA, Vranic M (1986) Hormonal and metabolic responses to intracarotid and intrajugular infusion of B-endorphin in normal dogs. Can J Physiol Pharmacol 64: 306–310
Radosevich PM, Williams PE, McRae JR, Lacy WW, Orth DN, Abumrad NN (1984) B-endorphin inhibits glucose production in the conscious dog. J Clin Invest 73: 1237–1241
Brubaker PL, Sun A, Vranic M (1987) Lack of effect of B-endorphin on basal or glucagon-stimulated hepatic glucose production in vitro metabolism. Metabolism 36: 432–437
Sacca L, Vigorito C, Cicala M, Corso G, Sherwin RS (1983) Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol 245: E294-E302
Cherrington AD, Fuchs H, Stevenson RW, Williams PE, Alberti KGMM, Steiner KE (1984) Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs. Am J Physiol 247: E137-E144
Dave JR, Rubinstein N, Eskay RL (1985) Evidence that B-endorphin binds to specific receptors in rat peripheral tissues and stimulates the adenylate cyclose-adenosine 3,5-menophosphate system. Endocrinology 117: 1389–1396
Shimazu T (1981) Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 20: 343–356
Pardridge WM (1984) Transport of nutrients and hormones through the blood-brain barrier. Fed Proc 43: 201–204
Eigler N, Sacca L, Sherwin RS (1979) Synergistic interactions of physiologic increments of glucagon, epinephrine and cortisol in the dog. J Clin Invest 63: 114–123
Shamoon H, Hendler R, Sherwin RS (1980) Altered responsiveness to cortisol, epinephrine and glucagon in insulin-infused juvenile-onset diabetes. Diabetes 29: 284–291
Lickley HLA, Kemmer FW, Doi K, Vranic M (1983) Glucagon suppression improves glucoregulation in moderate but not severe diabetes. Am J Physiol 245: E424-E429
Shaar CJ, Frederickson RCA, Dininger NB, Jackson L (1977) Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin — evidence for regulation by an endogenous opioid peptide in brain. Life Sci 21: 853–860
Metcalfe P, Johnston DG, Nosadini R, Orksov H, Alberti KGMM (1981) Metabolic effects of acute and prolonged growth hormone excess in normal and insulin-deficient man. Diabetologia 20: 123–128
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
El-Tayeb, K.M.A., Vranic, M., Brubaker, P.L. et al. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs. Diabetologia 30, 745–754 (1987). https://doi.org/10.1007/BF00297000
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00297000